Assessing Safety of Cervical Spine Fusion With NMP®

Part of paid clinical trials in Jasper, Alabama.

Sponsor
Red Rock Regeneration Inc.
Study ID
NCT07245940
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Natural Matrix Protein (NMP) Fibers — BIOLOGICAL
    Human bone allograft
  • Cervical interbody fusion — PROCEDURE
    Procedure that involves removing the intervertebral disk from the disk space between between 2 or more vertebrae between C2 and T1. When the disk space has been cleared out, the surgeon fills the void between the vertebrae with a bone void filler.

Study Details

The goal of this retrospective chart review study is to assess safety of NMP® in the treatment of cervical spine degenerative conditions by assessing the incidence and nature of AEs in follow-up (minimum of 90 days and up to 2 year post-operatively) as well as reoperation rates.

Key Dates

Start date
Jan 15, 2026
Status verified
Nov 2025
Primary completion
Jun 1, 2026
Completion
Aug 1, 2026

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Cervical Interbody Fusion with NMP
    Subject has undergone cervical interbody spine fusion between C2 and T1 where NMP fibers have been used as a bone void filler with minimum of 90-day post-operative follow up data available

Primary Outcome Measure

Adverse Event Reporting [ Time Frame: 90 days - 24 months postoperatively ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Alabama Back InstituteJasperAlabama35501-

Find similar trials in Jasper, AL

By research site
Alabama Back Institute· Jasper, AL

Related Studies